[XENE] YoY Quarter Result on 30-Sep-2021 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 30.14%
YoY- -74.42%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 132 8,124 6,554 3,500 0 264 -
PBT -48,619 -37,737 -15,650 -9,058 -8,866 -14,383 -7,742 35.80%
Tax -157 -587 -205 -203 5 678 -902 -25.26%
NP -48,462 -37,150 -15,445 -8,855 -8,871 -14,383 -7,742 35.73%
Tax Rate - - - - - - - -
Total Cost 48,462 37,282 23,569 15,409 12,371 14,383 8,006 34.98%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 -28,143.94 -190.12 -135.11 -253.46 0.00 -2,932.58 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.73 -0.59 -0.37 -0.25 -0.34 -0.71 -0.43 9.21%
EPS Diluted -0.73 -0.57 -0.37 -0.25 -0.34 -0.71 -0.43 9.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.